BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27434182)

  • 1. LATS2 Positively Regulates Polycomb Repressive Complex 2.
    Torigata K; Daisuke O; Mukai S; Hatanaka A; Ohka F; Motooka D; Nakamura S; Ohkawa Y; Yabuta N; Kondo Y; Nojima H
    PLoS One; 2016; 11(7):e0158562. PubMed ID: 27434182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
    Dozmorov MG
    Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Chk1/2-Lats2-14-3-3 signaling pathway regulates P-body formation in response to UV damage.
    Okada N; Yabuta N; Suzuki H; Aylon Y; Oren M; Nojima H
    J Cell Sci; 2011 Jan; 124(Pt 1):57-67. PubMed ID: 21118956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone variants H2A.Z and H3.3 coordinately regulate PRC2-dependent H3K27me3 deposition and gene expression regulation in mES cells.
    Wang Y; Long H; Yu J; Dong L; Wassef M; Zhuo B; Li X; Zhao J; Wang M; Liu C; Wen Z; Chang L; Chen P; Wang QF; Xu X; Margueron R; Li G
    BMC Biol; 2018 Sep; 16(1):107. PubMed ID: 30249243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
    Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
    Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis.
    Abe Y; Ohsugi M; Haraguchi K; Fujimoto J; Yamamoto T
    FEBS Lett; 2006 Feb; 580(3):782-8. PubMed ID: 16413547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lats2 is a negative regulator of myocyte size in the heart.
    Matsui Y; Nakano N; Shao D; Gao S; Luo W; Hong C; Zhai P; Holle E; Yu X; Yabuta N; Tao W; Wagner T; Nojima H; Sadoshima J
    Circ Res; 2008 Nov; 103(11):1309-18. PubMed ID: 18927464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis.
    Suzuki H; Yabuta N; Okada N; Torigata K; Aylon Y; Oren M; Nojima H
    J Cell Sci; 2013 Oct; 126(Pt 19):4358-68. PubMed ID: 23886938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of Polycomb Repressive Complex 2 to RNA by Short Repeats of Consecutive Guanines.
    Wang X; Goodrich KJ; Gooding AR; Naeem H; Archer S; Paucek RD; Youmans DT; Cech TR; Davidovich C
    Mol Cell; 2017 Mar; 65(6):1056-1067.e5. PubMed ID: 28306504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long noncoding RNA Gm15055 represses Hoxa gene expression by recruiting PRC2 to the gene cluster.
    Liu GY; Zhao GN; Chen XF; Hao DL; Zhao X; Lv X; Liu DP
    Nucleic Acids Res; 2016 Apr; 44(6):2613-27. PubMed ID: 26615201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinase shRNA screen links LATS2 and the pRB tumor suppressor.
    Tschöp K; Conery AR; Litovchick L; Decaprio JA; Settleman J; Harlow E; Dyson N
    Genes Dev; 2011 Apr; 25(8):814-30. PubMed ID: 21498571
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li L; Dong L; Wang Y; Zhang X; Yan J
    Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl.
    Reuven N; Adler J; Meltser V; Shaul Y
    Cell Death Differ; 2013 Oct; 20(10):1330-40. PubMed ID: 23852372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LATS2 is a tumor suppressor gene of malignant mesothelioma.
    Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
    Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updating and interaction of polycomb repressive complex 2 components in maize (Zea mays).
    Ni J; Ma X; Feng Y; Tian Q; Wang Y; Xu N; Tang J; Wang G
    Planta; 2019 Aug; 250(2):573-588. PubMed ID: 31127375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
    Furth N; Aylon Y
    Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
    Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
    Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.